미시간의 제2형 당뇨병 임상 시험
제2형 당뇨병 관련 연구 26개가 미시간 내 여러 지역에서 참여자를 모집하고 있습니다.
미시간의 도시
공식 연구 텍스트(영어)
A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity
- Aa Mrc Llc, Flint
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT07595549A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
- Henry Ford Hospital, Detroit
- Trinity Health Michigan Heart, Ypsilanti
피험자 모집 중건강한 지원자 환영
55세 이상 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT06112418A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
- Revival Research Institute, LLC, Dearborn
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07783802A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
- Research Site, Farmington Hills
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07784270A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar
- Northern Pines Health Center - Buckley, Buckley
- Revival Research Institute, LLC - Dearborn, Dearborn
- Arcturus Healthcare - Troy Internal Medicine Research Division, Troy
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT07754461A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
- AURORA-2 Clinical Site, Southfield
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07743450EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Revival Research Institute, LLC - Dearborn, Dearborn
- Aa Mrc Llc, Flint
- Elite Research Center, LLC, Flint
- 외 1개
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT07064473A Study of CX11 Tablets in Patients With Type 2 Diabetes Mellitus
- Elixia Health - Michigan Kidney Consultants, LLC - Elixia - PPDS, Pontiac
피험자 모집 중2상
18세 ~ 75세 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT07340320Study to Assess the Effects of ALN-ANG3 in Adult Participants With Diabetic Kidney Disease
- University of Michigan, Ann Arbor
- Elixia Michigan Kidney Consultants, Pontiac
피험자 모집 중2상
18세 ~ 80세 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT07271186A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus
- Research Site, Southfield
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07662213A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and Adolescents With Type 2 Diabetes
- Great Lakes Research Inst., Southfield
피험자 모집 중3상
10세 ~ 18세 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07282613Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D)
- Oakland Medical Research Center, Troy
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT07296484Mechanisms of Fatigability With Diabetes
- University of Michigan, Ann Arbor
피험자 모집 중
30세 ~ 85세 · 모든 성별 · 2026. 9. 1. 업데이트됨 · NCT04442451AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications
- Henry Ford Health System, Detroit
- Elite Research Center, Flint
- Arcturus Healthcare, PLC., Troy
- 외 1개
피험자 모집 중3상
45세 이상 · 모든 성별 · 2026. 9. 1. 업데이트됨 · NCT07797335A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
- Research Site, Troy
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT07662109A Phase III Study to Investigate the Efficacy and Safety of Elecoglipron Alone or in Combination With Dapagliflozin Compared With Placebo in Adults With Type 2 Diabetes Mellitus
- Research Site, Southfield
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 31. 업데이트됨 · NCT07662044Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes
- Henry Ford Health System, Detroit
피험자 모집 중
18세 ~ 80세 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07599982Efficacy of the Omnipod® 6 System Compared With the Omnipod® 5 System
- Henry Ford Health Systems, Detroit
피험자 모집 중
14세 ~ 75세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT07579702Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes
- Henry Ford Health, Detroit
피험자 모집 중
18세 ~ 75세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT07521475Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
- University of Michigan, Ann Arbor
피험자 모집 중관찰 연구건강한 지원자 환영
14세 ~ 18세 · 모든 성별 · 2026. 7. 13. 업데이트됨 · NCT06007404Implementation pRogram to Improve Screening and Management for CKD in Diabetes (Program 1) (IRIS-CKD)
- University of Michigan, Ann Arbor
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 6. 16. 업데이트됨 · NCT06906627Implementation pRogram to Improve Screening and Management for CKD in Diabetes (IRIS-CKD) (Program 2)
- University of Michigan, Ann Arbor
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 6. 16. 업데이트됨 · NCT06906640Michigan Men's Diabetes Project III(MenDIII): Mind and Motion
- University of Michigan, Ann Arbor
피험자 모집 중
18세 이상 · 남성 · 2026. 6. 12. 업데이트됨 · NCT06574035Mechanism of SGLT2 Inhibition in the Kidney
- University of Michigan, Ann Arbor
피험자 모집 중4상참여자 보상 언급
18세 ~ 80세 · 모든 성별 · 2026. 6. 11. 업데이트됨 · NCT06291155HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
- Arcturus Healthcare, PLC, Troy Internal Medicine Research Division, Troy
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 4. 23. 업데이트됨 · NCT07546929RESET System Pivotal Trial (Rev F)
- Michigan Medicine, Division of Gastroenterology and Hepatology, Ann Arbor
피험자 모집 중
22세 ~ 65세 · 모든 성별 · 2024. 7. 18. 업데이트됨 · NCT04101669ClinicalTrials.gov 출처, 2026. 9. 30. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.